公司简介

Personalis, Inc. is a provider of advanced genomic sequencing and analytics solutions to support the development of personal cancer vaccines and other next-generation cancer immunotherapies.

主要成员

John West、Carol J. Tillis、Christian Haudenschild、Richard Chen、Atul Butte

产品/服务

• 肿瘤基因组
• 科技服务

Oncology Diagnostics

ACE CancerPlus Test.

NGS assays and analytics	help biopharma, researchers, and clinicians gain deeper insights into disease biology and make smarter, more informed decisions.
Immuno-Oncology	ACE ImmunoID Platform.

融资信息

融资轮次	融资日期	投资方	融资额度
Series A	2011-08	未披露	$20M
Series B	2013-10	Abingworth	$22M
Series C	2015-01	Lightspeed Venture Partners	$33M

关联公司